Navigate to Other Sector


Healthcare Newsletter – July 2018

Poster drug of DTC marketing, Takeda’sEntyvio gets approval in Japan
Otsuka acquires Visterra – Emphasizes Potential of Platform Technologies in Targeted Drug Development
Improved Regulatory robustness in Biosimilar space directed at alleviating access concerns
Continued Indian Pharma Interest in seeking Ex-US Growth
Fund Raise Round-up for the Month
Expanding use of Continuous Glucose Monitors &Pervasive Pursuit of Connected Care across Devices& Diagnostics

Contact us to know more…

Discussion — No responses

Show Buttons
Hide Buttons